These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 6234801)

  • 1. A genetic study of red cell osmotic fragility in Huntington's disease.
    McCormack MK; Lazzarini A; Toke D; Lepore F
    Am J Med Genet; 1984 May; 18(1):5-11. PubMed ID: 6234801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered red cell osmotic fragility in Huntington disease (HD).
    McCormack MK; Ullman J; Lazzarini A
    Am J Med Genet; 1982 Jan; 11(1):53-9. PubMed ID: 6461249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulation of Huntington's disease onset.
    Markson LE; Chase GA; Brookmeyer R
    Genet Epidemiol; 1989; 6(3):451-9. PubMed ID: 2526776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of human erythrocyte membranes in normal people and in Huntington's chorea patients].
    Zakharov SF; Shandala AM; Shcheglova MV; Gromov PS; Insarova NG; Sychova VA; Markova ED; Shishkin SS; Ivanova-Smolenskaia IA
    Vopr Med Khim; 1990; 36(6):71-3. PubMed ID: 1963719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease.
    Mazziotta JC; Phelps ME; Pahl JJ; Huang SC; Baxter LR; Riege WH; Hoffman JM; Kuhl DE; Lanto AB; Wapenski JA
    N Engl J Med; 1987 Feb; 316(7):357-62. PubMed ID: 2949152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte osmotic fragility in hypertension and during diuretic therapy.
    Fasanmade AA
    West Afr J Med; 1999; 18(3):183-6. PubMed ID: 10593154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychosocial consequences of presymptomatic genetic testing. A retrospective study of testing for Huntington disease].
    Jakobsen LB; Malt U; Nilsson B; Rosenlund S; Heiberg A
    Tidsskr Nor Laegeforen; 1999 May; 119(13):1913-6. PubMed ID: 10382341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of preproenkephalin in striatal neurons from Huntington's disease patients.
    Richfield EK; Maguire-Zeiss KA; Cox C; Gilmore J; Voorn P
    Ann Neurol; 1995 Mar; 37(3):335-43. PubMed ID: 7695232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal and pathological aging of attention in presymptomatic Huntington's, Huntington's and Alzheimer's Disease, and nondemented elderly subjects.
    Peretti CS; Ferreri F; Blanchard F; Bakchine S; Peretti CR; Dobrescu A; Chouinard VA; Chouinard G
    Psychother Psychosom; 2008; 77(3):139-46. PubMed ID: 18277060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
    Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
    Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living with Huntington's disease: need for supportive care.
    Dawson S; Kristjanson LJ; Toye CM; Flett P
    Nurs Health Sci; 2004 Jun; 6(2):123-30. PubMed ID: 15130098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel population of progenitor cells expressing cannabinoid receptors in the subependymal layer of the adult normal and Huntington's disease human brain.
    Curtis MA; Faull RL; Glass M
    J Chem Neuroanat; 2006 Apr; 31(3):210-5. PubMed ID: 16533591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of Cl- transport in erythrocytes from patients with Huntington's disease.
    Białas WA
    Gen Physiol Biophys; 1984 Oct; 3(5):403-11. PubMed ID: 6239808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of 5-hydroxytryptamine by blood platelets in Huntington's chorea and Alzheimer type of presenile dementia.
    Tukiainen E; Wikström J; Kilpeläinen H
    Med Biol; 1981 Apr; 59(2):116-20. PubMed ID: 6458746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic discrimination: Huntington's disease and the Americans with Disabilities Act.
    Gin BR
    Columbia Law Rev; 1997 Jun; 97(5):1406-34. PubMed ID: 10175166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No difference in plasma or urinary F2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls.
    Montine TJ; Shinobu L; Montine KS; Roberts LJ; Kowall NW; Beal MF; Morrow JD
    Ann Neurol; 2000 Dec; 48(6):950. PubMed ID: 11117557
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic aspects of Huntington's chorea: results of a national survey.
    Hayden MR; Beighton P
    Am J Med Genet; 1982 Feb; 11(2):135-41. PubMed ID: 6461251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals.
    Penney JB; Young AB; Shoulson I; Starosta-Rubenstein S; Snodgrass SR; Sanchez-Ramos J; Ramos-Arroyo M; Gomez F; Penchaszadeh G; Alvir J
    Mov Disord; 1990; 5(2):93-9. PubMed ID: 2139171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Huntington's chorea: clinical aspects, genetics and current diagnosis].
    Spiegel R
    Ther Umsch; 1995 Dec; 52(12):814-20. PubMed ID: 8539653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependence of, and effects of inhibition and cellular aging on, chloride efflux across erythrocyte membranes in Huntington's disease.
    Butterfield DA; Markesbery WR
    J Neurol Sci; 1982; 57(1):29-39. PubMed ID: 6296324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.